BR0015153A - Derivados de higromicina - Google Patents

Derivados de higromicina

Info

Publication number
BR0015153A
BR0015153A BR0015153-0A BR0015153A BR0015153A BR 0015153 A BR0015153 A BR 0015153A BR 0015153 A BR0015153 A BR 0015153A BR 0015153 A BR0015153 A BR 0015153A
Authority
BR
Brazil
Prior art keywords
compounds
derivatives
above compounds
hygromycin
hygromycin derivatives
Prior art date
Application number
BR0015153-0A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Robert Gerald Ii Linde
Matthew Merrill Hayward
Takushi Kaneko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0015153A publication Critical patent/BR0015153A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"DERIVADOS DE HIGROMICINA". A invenção presente diz respeito a compostos com a fórmula <UM>1<MV> e aos seus sais farmaceuticamente aceitáveis, pro-fármacos e solvatos desses compostos, em que X, Y, V, W^ 1^, W^ 2^, Z^ 1^ e Z^ 2^ são tais como definidos neste documento. A invenção também diz respeito a composições contendo os compostos acima e a métodos de tratar infecções bacterianas e a protozoários em mamíferos pela administração dos compostos acima.
BR0015153-0A 1999-10-29 2000-10-09 Derivados de higromicina BR0015153A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16258199P 1999-10-29 1999-10-29
PCT/IB2000/001461 WO2001030795A1 (en) 1999-10-29 2000-10-09 Hygromycin derivatives

Publications (1)

Publication Number Publication Date
BR0015153A true BR0015153A (pt) 2002-07-16

Family

ID=22586256

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015153-0A BR0015153A (pt) 1999-10-29 2000-10-09 Derivados de higromicina

Country Status (32)

Country Link
US (1) US6562792B1 (pt)
EP (1) EP1224197A1 (pt)
JP (1) JP2003512473A (pt)
KR (1) KR20020063885A (pt)
CN (1) CN1382150A (pt)
AP (1) AP2002002494A0 (pt)
AR (1) AR023282A1 (pt)
AU (1) AU7549400A (pt)
BG (1) BG106727A (pt)
BR (1) BR0015153A (pt)
CA (1) CA2389191A1 (pt)
CO (1) CO5261498A1 (pt)
CZ (1) CZ20021355A3 (pt)
EA (1) EA200200292A1 (pt)
EE (1) EE200200228A (pt)
GT (1) GT200000185A (pt)
HK (1) HK1049672A1 (pt)
HU (1) HUP0203525A3 (pt)
IL (1) IL148577A0 (pt)
IS (1) IS6311A (pt)
MA (1) MA26838A1 (pt)
MX (1) MXPA02004360A (pt)
NO (1) NO20021850D0 (pt)
OA (1) OA12081A (pt)
PA (1) PA8505801A1 (pt)
PE (1) PE20010763A1 (pt)
PL (1) PL357083A1 (pt)
SK (1) SK5472002A3 (pt)
SV (1) SV2002000211A (pt)
TN (1) TNSN00211A1 (pt)
TR (1) TR200201145T2 (pt)
WO (1) WO2001030795A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410643A1 (en) 2000-06-02 2001-12-06 Pfizer Products Inc. Hygromycin a derivatives for the treatment of bacterial and protozoal infections
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7923439B2 (en) 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
EP3840743A4 (en) * 2018-08-20 2022-08-17 Northeastern University HYGROMYCIN A COMPOUNDS AND METHODS OF TREATING SPIROCHETE DISEASES
IL293592A (en) 2019-12-06 2022-08-01 Vertex Pharma Transduced tetrahydrofurans as sodium channel modulators
MX2023014378A (es) 2021-06-04 2023-12-15 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofurano carboxamidas como moduladores de canales de sodio.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1135400A1 (en) * 1998-12-02 2001-09-26 Pfizer Products Inc. Hygromycin a derivatives as antibacterial agents

Also Published As

Publication number Publication date
NO20021850L (no) 2002-04-19
PA8505801A1 (es) 2002-08-26
OA12081A (en) 2006-05-04
IL148577A0 (en) 2002-09-12
PE20010763A1 (es) 2001-07-25
HUP0203525A2 (hu) 2003-02-28
EE200200228A (et) 2003-06-16
AP2002002494A0 (en) 2002-06-30
NO20021850D0 (no) 2002-04-19
AR023282A1 (es) 2002-09-04
CZ20021355A3 (cs) 2002-11-13
SK5472002A3 (en) 2003-02-04
US6562792B1 (en) 2003-05-13
EP1224197A1 (en) 2002-07-24
CO5261498A1 (es) 2003-03-31
IS6311A (is) 2002-03-19
SV2002000211A (es) 2002-07-16
EA200200292A1 (ru) 2002-10-31
TNSN00211A1 (fr) 2005-11-10
GT200000185A (es) 2002-04-18
PL357083A1 (en) 2004-07-12
MA26838A1 (fr) 2004-12-20
BG106727A (bg) 2003-01-31
TR200201145T2 (tr) 2002-09-23
AU7549400A (en) 2001-05-08
CA2389191A1 (en) 2001-05-03
HUP0203525A3 (en) 2003-08-28
WO2001030795A1 (en) 2001-05-03
MXPA02004360A (es) 2002-11-07
CN1382150A (zh) 2002-11-27
JP2003512473A (ja) 2003-04-02
HK1049672A1 (zh) 2003-05-23
KR20020063885A (ko) 2002-08-05

Similar Documents

Publication Publication Date Title
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
BR9810021A (pt) Derivados 9-oxima-eritromicina
BR9913138A (pt) Derivados de quinolin-2-ona substituìdos com alquinila úteis como agentes contra o câncer
EA200100623A1 (ru) Кетолидные антибиотики
BR9900856A (pt) Antibioticos macrolideos de 3,6-cetal e enol-éter
BR9916781A (pt) 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais
ES2139079T3 (es) Compuestos inmunosupresores y antialergicos, tales como n-(3-oxohexanoil)-homoserina-lactona.
IL117875A0 (en) Pharmaceutical compositions for inhibiting th growth of cancers
EA200100396A1 (ru) Новые макролидные антибиотики
BR0006299A (pt) Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina
BR0015153A (pt) Derivados de higromicina
CO4970802A1 (es) Compuesto bencimidazol-5 sustituido con estabilidad mejorada
TR200003250T2 (tr) Higromisin A türevleri
GB9907055D0 (en) Antibacterial agents
HK1042300B (zh) 多環的噻唑體系和它們作為減食慾劑的用途
BR9915813A (pt) Derivados da higromicina a como agentes antibacterianos
TR200003249T2 (tr) 2&#39;&#39;-Deoksi higromisin türevleri
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
EA200201167A1 (ru) Производные гигромицина а для лечения бактериальных и протозойных инфекций
BRPI0407573A (pt) derivados de imidazo(4,5-b)quinolina e seu emprego como inibidores de sintase de no
BR0116412A (pt) Inibidores de pró-colagénio c-proteinase
BR0015156A (pt) Pró-drogas de higromicina a
UY26421A1 (es) Derivados de higromicina
MX165848B (es) Un producto de reaccion, un compuesto y un procedimiento para obtener un compuesto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.